ArticleBMC plant biology2026
Direct somatic embryogenesis, genetic fidelity assessment and GC-MS analysis of regenerated Crinum asiaticum L. Plants.
Article in BMC plant biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCrinum asiaticum L. is an important reservoir of phytocompounds containing galanthamine, lycorine, tazettine and others with diverse pharmacological uses. Due to high commercial demand for these promising compounds in pharmaceutical sector, an efficient in vitro micropropagation protocol optimization study was conducted via direct somatic embryogenesis in C. asiaticum. The regenerated plants were subject to genetic fidelity assessment; and the phytochemical composition was analysed and compared with donor plants. In this investigation, the bulb-scales were used as explants onto media containing different PGRs for various regeneration processes.
resultsIn media containing BAP and NAA, somatic embryos were formed directly on bulb-scale explant surfaces with the highest (95.83%) being at MS medium + 2.7 µM NAA + 4.4 µM BAP. The occurrence of somatic embryos at different stages was confirmed by histological and scanning electron microscopic (SEM) analysis. The embryos were later converted to shoots on 2.2-8.8 µM BAP augmented MS medium, with highest germination percentage of 75 ± 7.22 at 4.4 µM BAP. These regenerated plants were successfully transferred to medium containing NAA, IBA or IAA for rooting and the best rooting response (91.67% rooting frequency, 7.67 mean root numbers/shoot and 7.5 ± 0.6 cm average root length) was noted at 5.4 µM NAA. The plants were transferred to greenhouse with pretty good growth and survival. The genetic fidelity of tissue cultured plants was checked through cytological, flow cytometric and SCoT marker-based PCR technique. The root tips of in vitro raised and mother plants showed 2n = 44 chromosome numbers, and the flow cytometric histograms revealed similar fluorescence peaks with nuclear 2 C DNA content of 31.79 and 31.51pg, respectively, displaying no change in ploidy level. Six SCoT primers based genetic homogeneity study showed 42 scorable, monomorphic bands, confirming true-to-type regenerated plants. Finally, the GC-MS based metabolite profiling of in vivo and in vitro raised plants were conducted, which exhibited a wide range of bioactive compounds like tazettine, squalene, gamma-tocopherol, beta-sitosterol, glycidyl palmitate, glycidyl oleate of pharmacological significance.
conclusionsThe current study presents an effective method for genetically stable clonal propagation of C. asiaticum for extraction of compounds like tazettine, squalene, beta-sitosterol for pharmaceutical applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.